BPC-157

Productos

BPC-157 (Body Protection Compound 157) is a 15-amino acid peptide synthesized using solid-phase peptide synthesis. It is derived from human gastric juice and has been extensively researched for its regenerative and tissue-protective effects. Its remarkable stability in the gastric environment distinguishes it from most peptides, enabling both injectable and oral routes of administration.

Mecanismo de acción

BPC-157 activates the VEGFR2 pathway to stimulate angiogenesis and promotes nitric oxide synthesis to improve blood vessel dilation and circulation. It up-regulates growth factors including EGR-1, activates FAK-paxillin complexes for cell migration and cytoskeletal reorganization, and stimulates the JAK-2 signaling pathway for cell survival and immune modulation.

Principales ventajas

Angiogenesis & Tissue Repair — Activates the VEGFR2 pathway to promote new blood vessel formation. Enhances nitric oxide production, improving oxygen and nutrient delivery to damaged areas. Clinical evidence shows 7 of 12 patients with chronic knee pain experienced relief lasting over six months after a single BPC-157 injection.

Endothelial Function Support — Modulates caveolin-1 interaction with eNOS through the Src kinase pathway, enabling sustained nitric oxide production and maintained vasodilation for continuous blood flow to healing tissues.

Cellular Signaling & Repair — Activates FAK-paxillin complexes for wound cell migration, stimulates JAK-2 for cell survival, and triggers EGR-1 as a master transcriptional switch for organized healing.

Gut Health Support — As a gastric juice-derived peptide, BPC-157 promotes mucosal integrity throughout the gastrointestinal tract, enhances growth hormone receptor expression, modulates nitric oxide systems for mucosal blood flow, and reduces pro-inflammatory cytokines.

Referencias

1. Perovic D, et al. Novel therapeutic effects in rat spinal cord injuries by the administration of BPC 157 therapy. *Curr Issues Mol Biol.* 2022;44:1901–1927.
2. Japjec M, et al. Stable gastric pentadecapeptide BPC 157 as a therapy for the disable myotendinous junctions in rats. *Biomedicines.* 2021;9:1547.
3. Stuehr DJ, et al. A natural heme deficiency exists in biology that allows nitric oxide to control heme protein functions. *Bioessays.* 2023;45:e2300055.